Farmacéutica Hispanoamericana S.A. de C.V.

Farmacéutica Hispanoamericana (FH Mex) is a Mexican pharmaceutical laboratory founded in 2004 by Mexican and Spanish investors. The company specializes in the manufacturing and commercialization of high-quality generic medicines, distributing products across government, private, and impulse markets in Mexico. With a portfolio covering eight therapeutic lines, including respiratory, anti-infectives, and cardiovascular treatments, the company operates as a key supplier for federal health entities. They maintain a production facility in Mexico City and are actively involved in consolidated public health procurement processes.